SUZANNE SUROVEC: Open Payments
NPI 1861664385 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 8 payments from 7 companies in 2025. Trend: 2023 $300 · 2024 $192 · 2025 $652
Food & beverage: $531Education: $121
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $246 |
| Caris MPI, Inc. | 1 | $133 |
| Genmab U.S., Inc. | 1 | $109 |
| SEAGEN INC. | 1 | $95 |
| ABBVIE INC. | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: MI CANCER SEEK, LYNPARZA, Tivdak, ELAHERE, KEYTRUDA, JEMPERLI.
Industry payments across OH — which companies pay providers there.
